Sanovel Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Private

  • Employees
  • 1,697

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 1

Sanovel General Information

Description

Manufacturer and distributor of generic drugs intended to foster long and healthy lives. The company produces anti-inflammatory, anti-asthmatic, and antibiotic medication and conducts research and development at its other facility, thereby enabling access to pharmaceuticals for a range of treatments.

Contact Information

Website
www.sanovel.com.tr
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • River Plaza Esentepe Mahallesi Bahar Sokak Number 13
  • Kat:10, Levent
  • 34394 Istanbul
  • Turkey
+90 (0212)
Primary Industry
Pharmaceuticals
Vertical(s)
Manufacturing
Corporate Office
  • River Plaza Esentepe Mahallesi Bahar Sokak Number 13
  • Kat:10, Levent
  • 34394 Istanbul
  • Turkey
+90 (0212)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanovel Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanovel‘s full profile, request access.

Request a free trial

Sanovel Patents

  • 599

    Total Documents Applications and Grants

  • Total Patents Families

  • 202

    Granted

  • 161

    Pending

  • Expiring in next 12 mo

Sanovel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4527378-A1 A film coated tablet of brivaracetam Pending 10-Jun-2024
EP-4505996-A1 An oral solution comprising brivaracetam Pending 11-Aug-2023
EP-4505994-A1 Oral solution formulation comprising brivaracetam Pending 11-Aug-2023
EP-4505995-A1 Oral solution composition comprising brivaracetam Pending 11-Aug-2023
EP-4497434-A1 A film coated tablet formulation comprising empagliflozin Pending 26-Jul-2023 A61K9/2866
To view Sanovel’s complete patent history, request access »

Sanovel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sanovel Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sanovel‘s full profile, request access.

Request a free trial

Sanovel FAQs

  • When was Sanovel founded?

    Sanovel was founded in 1983.

  • Where is Sanovel headquartered?

    Sanovel is headquartered in Istanbul, Turkey.

  • What is the size of Sanovel?

    Sanovel has 1,697 total employees.

  • What industry is Sanovel in?

    Sanovel’s primary industry is Pharmaceuticals.

  • Is Sanovel a private or public company?

    Sanovel is a Private company.

  • What is the current valuation of Sanovel?

    The current valuation of Sanovel is .

  • What is Sanovel’s current revenue?

    The current revenue for Sanovel is .

  • Who are Sanovel’s investors?

    Afendis Capital Partners, Davidson Kempner Capital Management, Metric Capital Partners, and Toksöz Grup have invested in Sanovel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »